Menstrual Health Equity as a Public Health Priority

Abstract

Menstrual health equity is increasingly recognized as a critical public health priority with implications for gender equality, social justice, and overall health outcomes. This review synthesizes current epidemiological data, explores the pathophysiological underpinnings of menstrual health disorders, examines risk factors and clinical features, and discusses diagnostic and management strategies. Recent advances and guideline recommendations are highlighted, underscoring the significance of menstrual health equity for healthcare professionals and policymakers.

Introduction

Menstrual health extends beyond the mere absence of disease, encompassing physical, psychological, and social well-being in relation to the menstrual cycle. Although menstruation is a universal physiological process, disparities in menstrual health management and access to resources persist globally. These inequities exacerbate gender-based health disparities and have far-reaching consequences for educational attainment, workplace productivity, and psychosocial well-being. This review aims to provide a comprehensive, evidence-based perspective on menstrual health equity, emphasizing its relevance as a public health priority.

Epidemiology / Disease Burden

Globally, an estimated 1.9 billion individuals menstruate, with approximately 500 million lacking adequate resources for menstrual hygiene management (MHM). Epidemiological studies reveal significant disparities in access to menstrual products, sanitation facilities, and health education, particularly in low- and middle-income countries (LMICs). Menstrual disorders, including dysmenorrhea, menorrhagia, and premenstrual syndrome, affect up to 75% of menstruating individuals at some point, often leading to absenteeism from school or work and diminished quality of life. Transgender and non-binary populations face additional barriers due to stigma and inadequate healthcare provider training. The burden of menstrual health inequity is further compounded by intersecting determinants such as poverty, disability, and geographic location.

Pathophysiology

The menstrual cycle is regulated by a complex interplay of hormonal signals involving the hypothalamic-pituitary-ovarian (HPO) axis. Disruptions in this axis may result in disorders such as amenorrhea, oligomenorrhea, or abnormal uterine bleeding. Chronic conditions, including polycystic ovary syndrome (PCOS) and endometriosis, contribute significantly to menstrual morbidity. Inadequate menstrual hygiene can precipitate reproductive tract infections, impact vaginal microbiota, and increase the risk of secondary complications such as pelvic inflammatory disease. Mechanistic studies have demonstrated that chronic stress, malnutrition, and environmental factors can further dysregulate menstrual function, amplifying health disparities in vulnerable populations.

Risk Factors

Socioeconomic status is a primary determinant of menstrual health equity. Limited financial resources restrict access to menstrual products and sanitary facilities. Cultural taboos and stigma perpetuate misinformation, discourage health-seeking behavior, and contribute to psychological distress. Adolescents, individuals with disabilities, and those living in humanitarian settings are particularly at risk. Additional risk factors include comorbid chronic conditions, limited health literacy, and inadequate access to reproductive health services. Environmental exposures, such as endocrine-disrupting chemicals, also play a role in the pathogenesis of menstrual disorders, especially in resource-limited settings where regulatory oversight may be lacking.

Clinical Features

Menstrual health disorders present with a spectrum of clinical features. Dysmenorrhea is characterized by crampy lower abdominal pain during menstruation, often accompanied by nausea, fatigue, and headaches. Menorrhagia involves excessive or prolonged menstrual bleeding, which may cause iron-deficiency anemia and related symptoms. Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) manifest as cyclical mood disturbances, irritability, and somatic complaints. Inadequate menstrual hygiene can result in vulvovaginal irritation, urinary tract infections, and increased susceptibility to reproductive tract infections. Mental health sequelae, including anxiety and depression, are increasingly recognized in individuals experiencing menstrual inequity or chronic menstrual disorders.

Diagnosis

Diagnosis involves a thorough history and physical examination, focusing on the menstrual pattern, associated symptoms, and impact on daily functioning. Laboratory investigations may include complete blood count, iron studies, thyroid function tests, and hormonal assays. Imaging modalities such as pelvic ultrasonography are indicated for the evaluation of structural causes of abnormal uterine bleeding or pelvic pain. The assessment of menstrual health equity also requires evaluation of access to menstrual products, hygiene facilities, and health education. Standardized screening tools for menstrual disorders and associated psychosocial distress are recommended to ensure comprehensive care, particularly in high-risk populations.

Treatment & Management

Management strategies for menstrual health disorders are multifaceted, addressing both medical and social determinants. Pharmacological options include nonsteroidal anti-inflammatory drugs (NSAIDs) for dysmenorrhea, hormonal contraceptives for cycle regulation, and antifibrinolytics for menorrhagia. Iron supplementation is indicated in cases of anemia. Education and counseling are integral to improving menstrual health literacy and dispelling myths. Addressing menstrual inequity requires ensuring universal access to affordable, high-quality menstrual products, sanitation facilities, and culturally sensitive health services. Advocacy and community engagement are essential to challenging stigma and promoting gender-responsive policies.

Recent Advances / Emerging Therapies

Innovations in menstrual health management include the development of biodegradable menstrual products, menstrual cups, and reusable pads, which offer sustainable alternatives for resource-limited settings. Mobile health (mHealth) interventions are being leveraged to deliver menstrual health education and facilitate remote symptom tracking. Recent clinical trials are evaluating the efficacy of novel hormonal agents and non-pharmacological therapies such as cognitive-behavioral interventions for PMS and PMDD. Policy initiatives, including the abolition of the "tampon tax" and free distribution of menstrual products in schools, are gaining traction in multiple countries. Ongoing research is focused on the intersectionality of menstrual health, exploring the unique needs of marginalized groups and informing targeted interventions.

Guideline Recommendations

Leading health organizations, including the World Health Organization (WHO) and the American College of Obstetricians and Gynecologists (ACOG), advocate for the integration of menstrual health into sexual and reproductive health frameworks. Guidelines recommend comprehensive menstrual health education in schools, routine screening for menstrual disorders, and the provision of menstrual products in healthcare and educational settings. Culturally competent care and the inclusion of menstrual health in national health policies are emphasized. Healthcare providers are encouraged to adopt a person-centered approach, recognizing the diverse needs and preferences of individuals across the gender spectrum.

Conclusion

Menstrual health equity is a multifaceted public health imperative that intersects with gender equality, social justice, and the right to health. Addressing menstrual inequities requires a collaborative, multidisciplinary approach encompassing clinical care, public health policy, education, and advocacy. Healthcare professionals play a pivotal role in recognizing and mitigating menstrual health disparities, supporting evidence-based interventions, and championing systemic change. Continued research and policy innovation are essential to achieving menstrual health equity and improving health outcomes for all individuals.